Emergent BioSolutions Inc. (EBS) Profit Margin
Emergent BioSolutions Inc. (EBS) gross and net profit margin history with trends. Analyze profit margins in Excel with MarketXLS.
Profit Margin Data
| Period | Net Profit Margin |
|---|---|
| 2016-12-31 | 10.59% |
| 2017-12-31 | 14.73% |
| 2018-12-31 | 8.01% |
| 2019-12-31 | 4.93% |
| 2020-12-31 | 24.05% |
| 2021-12-31 | 14.70% |
| 2022-12-31 | -19.66% |
| 2023-12-31 | -72.48% |
| 2024-12-31 | -18.26% |
| 2025-12-31 | 7.08% |
How EBS compares with sector peers
| Symbol | Company | Net profit margin (latest fiscal year) |
|---|---|---|
| UHS | Universal Health Services Inc. | 8.57% |
| IQV | IQVIA Holdings Inc. | 8.34% |
| ABBV | AbbVie Inc. | 6.91% |
| ENSG | The Ensign Group Inc. | 6.80% |
| ADUS | Addus HomeCare Corporation | 6.74% |
These are five companies in the same sector as EBS with a comparable annual net profit margin. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Emergent BioSolutions Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Profit_Margin("EBS", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | EBS | $4.45 | -0.45% | 1.75M |
| 3 | ||||
| 4 | ||||
| 5 |